Publication:
Transient hepatitis B surface antigenemia after neonatal hepatitis B immunization

Simple item page
dc.contributor.authorKöksal, N.
dc.contributor.authorAltinkaya, N.
dc.contributor.authorPerk, Y.
dc.contributor.buuauthorKöksal, Nilgün
dc.contributor.buuauthorAltınkaya, N.
dc.contributor.buuauthorPerk, Y.
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentÇocuk Sağlığı ve Hastalıkları Ana Bilim Dalı
dc.contributor.orcid0000-0002-6067-3886
dc.contributor.scopusid15056452900
dc.contributor.scopusid6506809147
dc.date.accessioned2025-05-13T14:33:47Z
dc.date.issued1996-01-01
dc.description.abstractFollowing immunization with hepatitis B vaccine, 39 infants were followed prospectively for hepatitis B surface antigen (HBsAg). A total of 69.2% of the infants tested positive for antigenemia at least once. Antigenemia was identified most often at 2-3 days (43.5%) and 5-6 days (43.5%) after immunization. The longest documented duration of antigenemia was 21 days. In all cases the antigenemia was transient and cleared by the 28th day post-vaccination.
dc.identifier.doi10.1111/j.1651-2227.1996.tb13961.x
dc.identifier.endpage 1502
dc.identifier.issn0803-5253
dc.identifier.issue12
dc.identifier.scopus2-s2.0-0029840216
dc.identifier.startpage1501
dc.identifier.urihttps://hdl.handle.net/11452/53005
dc.identifier.volume85
dc.indexed.scopusScopus
dc.language.isoen
dc.publisherBlackwell Publishing Ltd
dc.relation.journalActa Paediatrica, International Journal of Paediatrics
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectnewborn
dc.subjecthepatitis vaccine
dc.subjectHBsAg antigenemia
dc.subject.scopusHemodialysis; Hepatitis B Vaccine; Immunogenicity
dc.titleTransient hepatitis B surface antigenemia after neonatal hepatitis B immunization
dc.typeArticle
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/ Çocuk Sağlığı ve Hastalıkları Ana Bilim Dalı

Files

Collections